COVID-19 Impact : Our team has been closely monitoring the current developments to identify the potential impact of COVID-19 on stakeholders and business processes across the value chain of industries. A special section about COVID-19 will be covered with the report to help companies in defining sustainable strategies.
Cancer is a chronic disease caused by changes or mutations in the genetic material (DNA). Tumors form when abnormal cells starts growing out of control to form a mass. Cancer is categorized into two forms -blood cancers and solid tumors. Major classes of cancers are carcinomas, sarcomas, lymphomas, and leukemias. Carcinomas starts in the skin or in tissues covering glands or major organs. Major subtypes are adenocarcinoma and squamous cell carcinoma.
Lymphomas begins in the lymphatic system, a system of glands and vessels that carries lymph and white blood cells. On the other hand, leukemia is the cancer of blood-forming tissues such as bone marrow. Sarcomas develops in the connective tissues such as muscle or bones. However, soft-tissue sarcomas can begin in fatty tissues.
Treatment of cancer depends upon its stage. Radiotherapy and chemotherapy are preferred in the early stage of the disease. Some other treatment alternatives such as immunotherapy and gene therapy can also be used in the treatment of cancer. Rising cases of cancer have created many lucrative opportunities for the key market players.
As per the National Cancer Institute, in 2018, around 1,735,350 new cases of cancer were diagnosed in the United States of America. Compared to the past 5 years, 57 newly launched oncology therapeutics received approval for 89 indications recently. Some of these drugs can treat multiple tumor types.
The global oncology market is valued at USD 100.0 billion in 2020 and is anticipated to grow with a CAGR of 7.6% during the forecast period from 2020 to 2028. Increasing incidence of cancer, rising geriatric population, and growing healthcare expenditure are some key factors, which are fueling the growth of this market.
What does this Report Provide?
This report provides a detailed understanding of the global oncology demand from a qualitative and quantitative perspective with a forecast for the next 10 years. The report also provides dynamic indicators with potential impact on the market during the forecast period and an in-depth analysis of the leading companies operating in the global oncology market. The major market drivers, challenges, and opportunities for the global oncology market have also been covered in the market. This report also includes the market share of the leading companies operating in the oncology market, along with their drug class ion capacities and the growth strategies adopted by them.
Market Segmentation:
By Drug Class
By Indication
By End User
By Distribution Channel
By Region
North America Oncology Market
Europe Oncology Market
Asia Pacific Oncology Market
Middle East & Africa Oncology Market
South America Oncology Market
Major Companies: AbbVie Inc., AstraZeneca PLC, Astellas Pharma Inc., Bristol-Myers Squibb Company, Celgene Corporation, f. Hoffmann-La Roche ltd., Merck & Co., Inc., Johnson & Johnson (Janssen Global Services, LLC,), Novartis AG, Pfizer Inc, and others.
Objectives of this Report:
Customization:
This study is customized to meet your specific requirements:
For more information, contact: [email protected]
Single User (PDF)
3850Multi User (PDF)
5150Enterprise User (PDF)
7650Avail customized purchase options to meet your exact research needs.
Detailed scope covering all the major segments in the market
In line data validations to ensure data precision
Market recommendations supporting decision making processes
Round the clock analyst support to resolve your queries
Up to 15% additional free customization to meet your specific requirements